ACCESSION: MSBNK-SMB_Measured-HSA032P0114001
RECORD_TITLE: Uncharacterized; LC-ESI-QTOF; MS2; POSITIVE; Averaged data
DATE: 2025.04.02 (Averaged 2025.02.25, Processed 2025.02.25, Annotated 2025.03.31, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Yu et al. Front Cell Infect Microbiol. 2022,11,763507
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: REPOSITORY MetaboLights
COMMENT: DATASET_ID MTBLS3233
COMMENT: DATASET_TITLE The gut microbiome and metabolites are altered and interrelated in patients with rheumatoid arthritis
COMMENT: DATASET_AUTHORS Die Yu, Juping Du, Xia Pu, Liyuan Zheng, Shuaishuai Chen, Na Wang, Jun Li, Shiyong Chen, Shaobiao Pan, Bo Shen
COMMENT: MS1_M/Z_AVERAGED_THRES 15.000
COMMENT: MS2_M/Z_AVERAGED_THRES 20.000
COMMENT: DATASET_FILE_NUM 60
COMMENT: NUM_AVERAGED_SPEC 55
COMMENT: RAW_SPEC {'RA12-pos_406': {'bp': 28094.0, 'sum': 37891.0}, 'RA18-pos_384': {'bp': 25233.0, 'sum': 34523.0}, 'HC25-pos_392': {'bp': 23266.0, 'sum': 31024.0}, 'RA15-pos_404': {'bp': 22008.0, 'sum': 30102.0}, 'RA18-pos_396': {'bp': 21981.0, 'sum': 31084.0}, 'HC20-pos_405': {'bp': 19728.0, 'sum': 26239.0}, 'RA17-pos_407': {'bp': 19462.0, 'sum': 25988.0}, 'HC3-pos_387': {'bp': 18434.0, 'sum': 26223.0}, 'HC13-pos_409': {'bp': 18333.0, 'sum': 24001.0}, 'HC3-pos_374': {'bp': 17235.0, 'sum': 22985.0}, 'HC20-pos_393': {'bp': 14463.0, 'sum': 19896.0}, 'RA12-pos_394': {'bp': 13753.0, 'sum': 17837.0}, 'HC18-pos_402': {'bp': 12046.0, 'sum': 16368.0}, 'HC13-pos_397': {'bp': 11704.0, 'sum': 16280.0}, 'RA2-pos_390': {'bp': 11279.0, 'sum': 15030.0}, 'HC10-pos_391': {'bp': 11227.0, 'sum': 14657.0}, 'HC18-pos_391': {'bp': 10712.0, 'sum': 13421.0}, 'RA14-pos_371': {'bp': 10707.0, 'sum': 14992.0}, 'HC19-pos_410': {'bp': 10273.0, 'sum': 12798.0}, 'HC19-pos_398': {'bp': 10268.0, 'sum': 13271.0}, 'HC9-pos_400': {'bp': 10140.0, 'sum': 12994.0}, 'RA17-pos_394': {'bp': 9591.0, 'sum': 14345.0}, 'RA15-pos_390': {'bp': 9409.0, 'sum': 12039.0}, 'RA16-pos_398': {'bp': 9260.0, 'sum': 12181.0}, 'QC2-pos_402': {'bp': 8419.0, 'sum': 12433.0}, 'HC9-pos_386': {'bp': 8241.0, 'sum': 10991.0}, 'HC25-pos_380': {'bp': 8209.0, 'sum': 11011.0}, 'HC21-pos_398': {'bp': 7466.0, 'sum': 10567.0}, 'QC3-pos_398': {'bp': 7367.0, 'sum': 11227.0}, 'QC1-pos_389': {'bp': 7334.0, 'sum': 11374.0}, 'HC4-pos_403': {'bp': 7220.0, 'sum': 9844.0}, 'RA16-pos_409': {'bp': 6971.0, 'sum': 8665.0}, 'QC2-pos_387': {'bp': 6569.0, 'sum': 9314.0}, 'HC23-pos_399': {'bp': 5831.0, 'sum': 8545.0}, 'RA14-pos_358': {'bp': 5392.0, 'sum': 7376.0}, 'QC3-pos_410': {'bp': 4818.0, 'sum': 6900.0}, 'HC23-pos_387': {'bp': 4790.0, 'sum': 6700.0}, 'HC21-pos_410': {'bp': 4762.0, 'sum': 6801.0}, 'RA4-pos_393': {'bp': 4740.0, 'sum': 6655.0}, 'RA4-pos_405': {'bp': 4474.0, 'sum': 5790.0}, 'QC1-pos_376': {'bp': 4369.0, 'sum': 8138.0}, 'QC4-pos_410': {'bp': 4046.0, 'sum': 5494.0}, 'HC15-pos_405': {'bp': 4021.0, 'sum': 5415.0}, 'QC8-pos_396': {'bp': 3447.0, 'sum': 3956.0}, 'QC7-pos_410': {'bp': 2746.0, 'sum': 3466.0}, 'QC8-pos_409': {'bp': 2627.0, 'sum': 3365.0}, 'QC5-pos_404': {'bp': 2045.0, 'sum': 3148.0}, 'QC7-pos_398': {'bp': 2016.0, 'sum': 2729.0}, 'RA23-pos_392': {'bp': 1966.0, 'sum': 2475.0}, 'QC6-pos_403': {'bp': 1673.0, 'sum': 2396.0}, 'RA13-pos_427': {'bp': 1658.0, 'sum': 2218.0}, 'QC6-pos_415': {'bp': 1416.0, 'sum': 1772.0}, 'QC5-pos_415': {'bp': 1233.0, 'sum': 1945.0}, 'RA9-pos_420': {'bp': 682.0, 'sum': 1293.0}, 'RA21-pos_404': {'bp': 458.0, 'sum': 814.0}}
COMMENT: RETENTION_TIME_STDEV 0.007
COMMENT: PRECURSOR_M/Z_RAW 114.065962
COMMENT: PRECURSOR_M/Z_STDEV 0.000393
COMMENT: PRECURSOR_IN_MS1 mz 114.066328; int 413.153; delta(ppm) 6.349156
COMMENT: PROPOSED_CHARGE_STATE ND
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.460; C4H7N3O; [M+H]+; delta(ppm) 0.459937
COMMENT: PROPOSED_MF MS-FINDER 4.456; C4H7N3O; [M+H]+; delta(ppm) 0.453251
COMMENT: PROPOSED_MF SIRIUS5_Sirius 20.617; C4H7N3O; [M+H]+; delta(ppm) 0.453251
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C4H7N3O; [M+H]+; delta(ppm) 0.453251
COMMENT: PROPOSED_MF SIRIUS6_Sirius 32.591; C4H7N3O; [M+H]+; delta(ppm) 0.453251
COMMENT: PROPOSED_MF SIRIUS6_Sirius 8.462; C2H5N6; [M+H]+; delta(ppm) 12.224311
COMMENT: PROPOSED_MF SIRIUS6_Sirius 3.951; C6H9O2; [M+H]+; delta(ppm) -11.317533
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C4H7N3O; [M+H]+; delta(ppm) 0.453251
COMMENT: PROPOSED_COMPOUND SIMILARITY:GNPS 24.000; DDRJAANPRJIHGJ-UHFFFAOYSA-N; C4H7N3O; Massbank:KO002550 Creatinine1-Methylglycocyamidine
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.661; DDRJAANPRJIHGJ-UHFFFAOYSA-N; [M+H]+; CN1CC(=O)NC1=N
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.384; BTXYOFGSUFEOLA-UHFFFAOYSA-N; [M+H]+; CN1C=C(O)N=C1N
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.767; HZDLDFBKYBGNHG-UHFFFAOYSA-N; [M+H]+; CN(CCC#N)N=O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.000; PPVUWDCETZMPLT-UHFFFAOYSA-N; [M+H]+; C1C=CNN1C(=O)N
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.000; KFSQJVOLYQRELE-UHFFFAOYSA-M; [M+H]+; CCC(=CC)C([O-])=O
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 8.161; DDRJAANPRJIHGJ-UHFFFAOYSA-N; [M+H]+; Creatinine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.113; BTXYOFGSUFEOLA-UHFFFAOYSA-N; [M+H]+; 2-amino-1-methyl-imidazol-4-ol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.113; PPVUWDCETZMPLT-UHFFFAOYSA-N; [M+H]+; 1,3-dihydropyrazole-2-carboxamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.654; HZDLDFBKYBGNHG-UHFFFAOYSA-N; [M+H]+; 3-(N-Nitrosomethylamino)propionitrile
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; DDRJAANPRJIHGJ-UHFFFAOYSA-N; [M+H]+; Creatinine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.958; BTXYOFGSUFEOLA-UHFFFAOYSA-N; [M+H]+; 2-amino-1-methyl-imidazol-4-ol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.854; HZDLDFBKYBGNHG-UHFFFAOYSA-N; [M+H]+; 3-(N-Nitrosomethylamino)propionitrile
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.841; PPVUWDCETZMPLT-UHFFFAOYSA-N; [M+H]+; 1,3-dihydropyrazole-2-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.936; DDRJAANPRJIHGJ-UHFFFAOYSA-N; [M+H]+; 2-amino-3-methyl-4H-imidazol-5-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.371; HZDLDFBKYBGNHG-UHFFFAOYSA-N; [M+H]+; N-(2-cyanoethyl)-N-methylnitrous amide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.143; FOOFYKFJNMAAQE-UHFFFAOYSA-N; [M+H]+; N-ethyl-1,3,4-oxadiazol-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.082; YUTNQQHHUYYBFA-UHFFFAOYSA-N; [M+H]+; N-methyl-1-(1,2,4-oxadiazol-5-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.081; CIHQZPVUYBHNQO-UHFFFAOYSA-N; [M+H]+; 1-(1,2,4-oxadiazol-5-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.081; HKIXGXYGOILGSX-UHFFFAOYSA-N; [M+H]+; 2-(1,2,4-oxadiazol-5-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.057; XJUQLFVCCWNFJJ-UHFFFAOYSA-N; [M+H]+; N-methyl-1-(1,2,4-oxadiazol-3-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.056; XGKOIOPVLYCTRF-UHFFFAOYSA-N; [M+H]+; 5-amino-2-methyl-4H-pyrazol-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.056; LFSXUCZAZSQBPW-UHFFFAOYSA-N; [M+H]+; 1-(1,2,4-oxadiazol-3-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.055; HUSLEZCKWCUICB-UHFFFAOYSA-N; [M+H]+; 2-(1,2,4-oxadiazol-3-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.995; KXLLKSHFFVQKTQ-UHFFFAOYSA-N; [M+H]+; 2-cyanoethylurea
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.993; NZORXPUYHVZTQG-UHFFFAOYSA-N; [M+H]+; (3-amino-1H-pyrazol-5-yl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.984; YGVFIVSNVVUSCS-UHFFFAOYSA-N; [M+H]+; 5-amino-2-methyl-1H-pyrazol-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.921; XKKMMJLWDOKNEW-UHFFFAOYSA-N; [M+H]+; (1-methyltriazol-4-yl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.917; AUZHYHBJZVEQNI-UHFFFAOYSA-N; [M+H]+; 4-amino-2-methyl-1H-pyrazol-5-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.903; WEDYTSQNYJKOPC-UHFFFAOYSA-N; [M+H]+; (1-methyl-1,2,4-triazol-3-yl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.888; VUYWQWFWWHLKFG-UHFFFAOYSA-N; [M+H]+; 4-amino-5-methyl-1,2-dihydropyrazol-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.870; PKHVUMMJMYKRNO-UHFFFAOYSA-N; [M+H]+; 2-(triazol-1-yl)ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.868; CLVALLQETQTQMV-UHFFFAOYSA-N; [M+H]+; 2-(1,2,4-triazol-1-yl)ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.867; MKSFCAQPDWJPND-UHFFFAOYSA-N; [M+H]+; 5-(aminomethyl)-1,2-dihydropyrazol-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.866; CIFUFRVSHZKBEO-UHFFFAOYSA-N; [M+H]+; (4-methyl-1,2,4-triazol-3-yl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.863; IRPLFUJJHBGEAL-UHFFFAOYSA-N; [M+H]+; 3-amino-2-methyl-1H-pyrazol-5-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.860; DLLDJWMWMVUIDZ-UHFFFAOYSA-N; [M+H]+; (3-methyltriazol-4-yl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.858; HJEVQOSZWIDFQJ-UHFFFAOYSA-N; [M+H]+; 2-(2H-triazol-4-yl)ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.856; QUAQZVSGXQVIEP-UHFFFAOYSA-N; [M+H]+; (2-methyl-1,2,4-triazol-3-yl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.822; YOSYLAYVXLOORB-UHFFFAOYSA-N; [M+H]+; 2-(1,2,4-triazol-4-yl)ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.790; BMTFHVKZYIOHBE-UHFFFAOYSA-N; [M+H]+; (5-methyl-1H-1,2,4-triazol-3-yl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.790; HGPUJQWMCPURNO-UHFFFAOYSA-N; [M+H]+; 3-ethyl-1,2,4-oxadiazol-5-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.741; HNXYWYOVPHLAQF-UHFFFAOYSA-N; [M+H]+; N,4-dimethyl-1,2,5-oxadiazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.730; PFBCKBGKRFYNLE-UHFFFAOYSA-N; [M+H]+; (5-methyl-2H-triazol-4-yl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.729; MTHUPGKUEISSDE-UHFFFAOYSA-N; [M+H]+; 2-amino-N-(cyanomethyl)acetamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.702; BVNFZLFQKJYVDJ-UHFFFAOYSA-N; [M+H]+; 3,4-dimethyl-1H-1,2,4-triazol-5-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.632; KPBSGOLXLCARIL-UHFFFAOYSA-N; [M+H]+; (5-methyl-1,2,4-oxadiazol-3-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.622; YKTPXKSUWIQBML-UHFFFAOYSA-N; [M+H]+; (4-methyl-1,2,5-oxadiazol-3-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.606; NPBUMVMXXGQOEG-UHFFFAOYSA-N; [M+H]+; (3-methyl-1,2,4-oxadiazol-5-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.526; GZDJNVITGJORKZ-UHFFFAOYSA-N; [M+H]+; ethyl N'-cyanocarbamimidate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.518; KNIARYZRPMJYFH-UHFFFAOYSA-N; [M+H]+; 2-(1H-1,2,4-triazol-5-yl)ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.516; LODVFGWSULLZAU-UHFFFAOYSA-N; [M+H]+; 4-methoxy-1H-pyrazol-5-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.514; RTCYUGLJCAPLPD-UHFFFAOYSA-N; [M+H]+; (2-methyltriazol-4-yl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.513; XHSTYRIUVMKGDX-UHFFFAOYSA-N; [M+H]+; 5-ethyl-1,3,4-oxadiazol-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.508; OMFADAFZDYXVOK-UHFFFAOYSA-N; [M+H]+; 5-ethyl-1,2,4-oxadiazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.480; WYZRLXYOIMXEBO-UHFFFAOYSA-N; [M+H]+; 1-(1H-1,2,4-triazol-5-yl)ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.417; DSFUCCQCXNNWLA-UHFFFAOYSA-N; [M+H]+; 3-methoxy-1H-pyrazol-5-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.417; YWXPPKJKSSLZOD-UHFFFAOYSA-N; [M+H]+; 5-(methoxymethyl)-1H-1,2,4-triazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.396; OTERRMWTPZGJLB-UHFFFAOYSA-N; [M+H]+; 4-ethyl-1,2,5-oxadiazol-3-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -101.446; KXLLKSHFFVQKTQ; [M+H]+; 2-Cyanoethylurea
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -126.185; DDRJAANPRJIHGJ; [M+H]+; Kreatinin
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -133.329; HZDLDFBKYBGNHG; [M+H]+; 3-Methylnitrosaminopropionitrile
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -148.215; CMIPWACBRYWGPN; [M+H]+; 1-Cyano-2,3-dimethylisourea
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -214.518; OMFADAFZDYXVOK; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -230.973; CLVALLQETQTQMV; [M+H]+; triazolylethanol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -248.550; HGPUJQWMCPURNO; [M+H]+; Ambcb4035725
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -256.090; XHSTYRIUVMKGDX; [M+H]+; 2-NH2-5-ET-1,3,4-oxadiazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -264.229; RTCYUGLJCAPLPD; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -267.398; DLLDJWMWMVUIDZ; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -282.036; OTERRMWTPZGJLB; [M+H]+; 4-ethyl-1,2,5-oxadiazol-3-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -282.497; MKSFCAQPDWJPND; [M+H]+; Azamuscimol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -290.303; IRPLFUJJHBGEAL; [M+H]+; 5-amino-1-methyl-1H-pyrazol-3-ol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -293.647; PKHVUMMJMYKRNO; [M+H]+; 2-(1-triazolyl)ethanol
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.473; KXLLKSHFFVQKTQ; [M+H]+; 2-Cyanoethylurea
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -87.235; DDRJAANPRJIHGJ; [M+H]+; Kreatinin
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -87.636; XGKOIOPVLYCTRF; [M+H]+; 3-amino-1-methyl-4,5-dihydro-1H-pyrazol-5-one
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -121.195; OMFADAFZDYXVOK; [M+H]+; 5-Ethyl-1,2,4-oxadiazol-3-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -123.282; FOOFYKFJNMAAQE; [M+H]+; N-ethyl-1,3,4-oxadiazol-2-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -123.692; KXLLKSHFFVQKTQ; [M+H]+; 2-Cyanoethylurea
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -125.709; XHSTYRIUVMKGDX; [M+H]+; 5-Ethyl-1,3,4-oxadiazol-2-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -126.449; HGPUJQWMCPURNO; [M+H]+; 3-Ethyl-1,2,4-oxadiazol-5-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -138.916; PPVUWDCETZMPLT; [M+H]+; 5-Dihydro-1h-pyrazole-1-carboxamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -144.662; IRPLFUJJHBGEAL; [M+H]+; 5-amino-1-methyl-1H-pyrazol-3-ol
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -146.094; HZDLDFBKYBGNHG; [M+H]+; 3-(Methyl-D3-nitrosoamino)propionitrile
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.054; DDRJAANPRJIHGJ; [M+H]+; Kreatinin
COMMENT: CONFIDENCE Level 4: Unequivocal precursor ion formula C4H8N3O1; Top hit by both SIRIUS6_Zodiac and MS-FINDER; and SevenGoldenRules(1), SIRIUS5_Sirius(1), SIRIUS5_Zodiac(1);
CH$NAME: Uncharacterized
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Feces
AC$INSTRUMENT: UPLC system, AB SCIEX - TripleTOF 5600+ mass spectrometer, AB SCIEX
AC$INSTRUMENT_TYPE: LC-ESI-QTOF
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY 30 V
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 5.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 15.00; MS2(ppm) 20.00
AC$CHROMATOGRAPHY: COLUMN_NAME ACQUITY UPLC T3 column (1.8 Âµm, 100 mm x 2.1 mm; Waters)
AC$CHROMATOGRAPHY: FLOW_GRADIENT 0.0-0.5 min, 5% B; 0.5-7.0 min,` 100% B; 7.0-8.0 min, 100% B; 8.0-8.1 min, 5% B; 8.1-10.0 min, 5% B. 
AC$CHROMATOGRAPHY: FLOW_RATE 0.4 mL/min
AC$CHROMATOGRAPHY: RETENTION_TIME 0.811
MS$FOCUSED_ION: PRECURSOR_M/Z 114.066240
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-0006-9000000000-4e054454ca0d4e5fa161
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  42.0339586 26.9283 42.034270 24.9560 12.92 0.7668 46 f{C2H4N1}/3.17ppm,p-C2H4N2O1
  43.0290902 184.7964 43.029400 21.1717 66.67 0.8471 53 f{C1H3N2}/0.36ppm,p-C3H5N1O1
  44.0497272 999.0000 44.050035 21.2941 0.00 0.8531 54 f{C2H6N1}/5.71ppm,p-C2H2N2O1
  72.0447975 15.5338 72.044955 20.1125 9.62 0.5862 42 f{C3H6N1O1}/5.65ppm,p-C1H2N2
  86.0720545 17.4863 86.072270 21.4239 12.33 0.5996 46 f{C3H8N3}/9.07ppm,p-C1O1
  114.0667320 36.0716 114.067090 15.5874 23.78 1.0000 52 f{C4H8N3O1}/4.77ppm,p
PK$NUM_PEAK: 6
PK$PEAK: m/z int. rel.int.
  42.033959 26.93 26
  43.029090 184.80 184
  44.049727 999.00 999
  72.044798 15.53 15
  86.072054 17.49 17
  114.066732 36.07 36
//
